TICKERNERD
Menu
ALCALCHealthcare · Medical Instruments & Supplies

ALC Stock Forecast: Alcon AG Price Predictions for 2026-2027

Last close, 18 Aug 2026
$74
+1.46% on the day

The 26 Wall Street analysts covering Alcon AG hold a median 12-month price target of $86 — +16.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 69 of 100 as at 17 Aug 2026 — in the upper half.

Market cap
$35.9B
Ticker Nerd rank
69 / 100
Median analyst target
$86
Analysts covering
26
Total return, dividends reinvested
1W
−2.4%
1M
+4.7%
YTD
−6.2%
1Y
−16.1%
From 52W high
−18.0%
From 52W low
+18.6%
$62
$90
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ALC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Alcon AG on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 17 Aug 2026
69 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
96
Value
88
Accruals
75
Issuance
73
Quality
65
Revisions
65
Growth
51
Momentum
28
Size
7

Volatility (96): The share price has been relatively steady.

Momentum (28): The shares have been drifting down relative to others.

Size (7): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ALC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ALC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$60$70$80$90$100$110Oct 25Jan 26Apr 26Jul 26ALCHigh $103Median $86Low $62

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says26 analysts
20 Buy5 Hold1 Sell
Low $62Median $86High $103

The green dot is the last close — the median target sits +16.9% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
12 Aug 2026JP MorganMaintainsNeutral$78 → $78
12 Aug 2026MizuhoMaintainsOutperform$80 → $85
11 Aug 2026BTIGReiteratesBuy$82
11 Aug 2026NeedhamMaintainsBuy$95 → $98
15 July 2026MizuhoMaintainsOutperform—
15 July 2026MizuhoMaintainsOutperform$85 → $80
8 May 2026BarclaysMaintainsEqual-Weight—
7 May 2026BairdMaintainsOutperform—
7 May 2026MizuhoMaintainsOutperform—
7 May 2026Wells FargoMaintainsOverweight—
6 May 2026BTIGMaintainsBuy—
6 May 2026NeedhamMaintainsBuy—
23 Mar 2026BTIGReiteratesBuy—
9 Mar 2026StifelMaintainsHold—
26 Feb 2026BarclaysMaintainsEqual-Weight—
26 Feb 2026NeedhamMaintainsBuy—
26 Feb 2026Wells FargoUpgradeOverweight—
25 Feb 2026BTIGMaintainsBuy—
9 Jan 2026StifelDowngradeHold—
11 Dec 2025B of A SecuritiesDowngradeUnderperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ALC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

ALC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.8%
Analysts raising
2
Analysts cutting
5
Fundamentals

Alcon AG (ALC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
56.7×

Cheaper than 13% of US stocks

Price / sales
3.3×

Cheaper than 39% of US stocks

Price / book
1.7×

Cheaper than 53% of US stocks

EV / EBITDA
16.5×

Cheaper than 21% of US stocks

Growth & margins
Revenue growth (YoY)
8.7%

Higher than 49% of US stocks

Earnings growth (YoY)
−100.0%

Higher than 1% of US stocks

Gross margin
56.4%

Higher than 69% of US stocks

Operating margin
14.6%

Higher than 72% of US stocks

Net margin
5.9%

Higher than 62% of US stocks

Returns & dividend
Return on equity
2.9%

Higher than 49% of US stocks

Return on assets
2.8%

Higher than 64% of US stocks

Dividend yield
1.9%

Higher than 44% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ALC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
ALCAlcon AG$35.9B
69
RMDResMed, Inc.$32.2B
71
MDLNMedline, Inc.$45.8B
18
BDXBecton, Dickinson & Co.$50.2B
92
WSTWest Pharmaceutical Services, Inc.$24.9B
93
SOLVSolventum Corp.$15.1B
89
COOThe Cooper Cos., Inc.$14.7B
77

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Alcon AG — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ALC news & analysis

Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy

Seeking Alpha · 17 Aug 2026positive

Alcon reported strong core operating profit, up 17% excluding a one-time non-cash $402 million charge, and raised its full-year 2026 profit forecast for the second consecutive quarter. A discounted cash flow valuation indicates the stock is trading close to its intrinsic value.

Why it matters — Alcon watchers would note the company's continued strengthening of its profitability outlook, as it upgraded its 2026 profit forecast for the second straight quarter.

Bill Ackman once exited Netflix stake in a huff. Why he's buying the streaming giant again as well as these five stocks.

Market Watch · 13 Aug 2026neutral

Bill Ackman's Pershing Square added Netflix and five other stocks to its portfolio in the last six months, after previously exiting a stake in the streaming giant.

Why it matters — As a major consumer and entertainment industry investor, Ackman's portfolio moves can signal shifting sector trends that may indirectly impact Alcon's market dynamics.

Alcon Inc. (ALC) Q2 2026 Earnings Call Transcript

Seeking Alpha · 11 Aug 2026neutral

Seeking Alpha published the transcript of Alcon Inc.'s Q2 2026 earnings call, covering the company's second-quarter 2026 financial results and management commentary.

Why it matters — The transcript gives Alcon watchers direct access to management's own words on the company's quarterly performance and outlook.

Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs

Zacks Investment Research · 11 Aug 2026positive

Alcon reported Q2 earnings and revenue that beat analyst estimates, driven by gains in equipment and ocular health, and raised its 2026 EPS outlook.

Why it matters — The earnings beat and raised 2026 outlook suggest stronger-than-expected operational performance, which could support investor confidence in Alcon's growth trajectory.

Eye care company Alcon raises profitability outlook, cuts tariff hit estimate

Reuters · 11 Aug 2026positive

Alcon raised its profitability (profit) guidance for the full year and lowered its estimated tariff impact to $40 million to $90 million, factoring in an anticipated refund of about $60 million from the U.S. government. The company made the announcement on Monday.

Why it matters — This matters for Alcon watchers because a higher profit outlook and a reduced tariff impact signal improved full-year earnings expectations for the eye care company.

FAQ

Frequently asked questions about ALC stock

What is the ALC stock price forecast for 2026-2027?

The 26 Wall Street analysts covering Alcon AG have a median 12-month price target of $86, with estimates ranging from $62 to $103. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ALC stock a buy right now?

Of the 26 analysts covering Alcon AG, 20 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Alcon AG 69 out of 100 across roughly 4,600 US stocks as at 17 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ALC?

As at 17 Aug 2026, Alcon AG ranks 69 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (96 of 100).

Will ALC stock go up?

No one can know that. What the data says: the median 12-month target from 26 analysts implies +16.9% from the last close, and Ticker Nerd's factor model ranks Alcon AG 69 out of 100 as at 17 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ALC stock forecast for 2030?

No analyst covering Alcon AG publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $62 to $103 over the next 12 months.

How has ALC stock performed over the past year?

Alcon AG returned -16.1% over the 12 months to 18 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Alcon AG do?

Alcon Inc. is a global eye care company that develops, manufactures, and markets products for vision health and ophthalmic surgery.

What is the latest news on ALC?

The most recent item we track (Seeking Alpha, 17 Aug 2026): "Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy". Alcon reported strong core operating profit, up 17% excluding a one-time non-cash $402 million charge, and raised its full-year 2026 profit forecast for the second consecutive quarter. A discounted cash flow valuation indicates the stock is trading close to its intrinsic value.

Company

About Alcon AG.

Alcon Inc. is a global eye care company that develops, manufactures, and markets products for vision health and ophthalmic surgery. Its portfolio includes surgical equipment and devices, intraocular lenses, consumables, and pharmaceutical eye drops used in procedures and treatments for eye diseases and disorders. The company also offers consumer vision care products designed for everyday eye health, including contact lens-related solutions and other routine care items. Alcon Inc. operates through its Surgical and Vision Care segments, serving eye care professionals, hospitals, clinics, and consumers across international markets. Headquartered in Geneva, Switzerland, Alcon Inc. is recognized as a major participant in the global ophthalmology and vision care industry.

CEO Mr. David J. Endicott · 25,000 employees · Switzerland · https://www.alcon.com